Dasatinib Norameda

Medicinal product

(Invented) name

Dasatinib Norameda

Active substance (s)

Dazatinibas

Strength

70 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L01EA02, dasatinib

Marketing authorisation holder

UAB Norameda, Lietuva

Date of authorisation

2020-02-10

Date of renewal

2024-03-14

Documents

4510-12_pakuotes lapelis_2024-03-14.docx

4510-12_Dasat_Norameda_perr2024-03-14.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

NL/H/4592/003/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Tabletėje yra:	1 vnt.
Dazatinibas	70 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
103237	89338	1089338	lizdinė plokštelė	N56		Receptinis	LT/1/20/4512/001	Netiekiama	-	-	No	-	-
103238	89339	1089339	lizdinė plokštelė	N60		Receptinis	LT/1/20/4512/002	Netiekiama	-	-	No	-	-
103239	89340	1089340	dalomoji lizdinė plokštelė	N56x1		Receptinis	LT/1/20/4512/003	Netiekiama	-	-	No	-	-
103240	89341	1089341	dalomoji lizdinė plokštelė	N60x1		Receptinis	LT/1/20/4512/004	Netiekiama	-	-	No	-	-
103241	89342	1089342	talpyklė	N60		Receptinis	LT/1/20/4512/005	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2024-03-14	Perregistruotas
2020-02-10	Registruotas